CIK 0000876343 · Biological Products, (No Diagnostic Substances) (SIC 2836) · NYSE · incorporated in CA · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 14.6 M | 8.9 M | 14.7 M | |
| Net income (USD) | -26.3 M | -43.0 M | ||
| Diluted EPS (USD/shares) | -0.28 | -0.12 | -0.15 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-07-29 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-06-12 | 8-K | 8-K items 5.07,8.01 | 2026-06-09 |
| 2026-05-12 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-12 | 8-K | 8-K items 2.02,9.01 | 2026-05-12 |
| 2026-04-29 | ARS | ARS | 2025-12-31 |
| 2026-04-29 | DEFA14A | DEFA14A | |
| 2026-04-29 | DEF 14A | DEF 14A | 2026-04-29 |
| 2026-03-23 | EFFECT | EFFECT items ,, | |
| 2026-03-19 | CORRESP | CORRESP | |
| 2026-03-16 | UPLOAD | UPLOAD | |
| 2026-03-12 | 4 | 4 | 2026-03-12 |
| 2026-03-11 | S-3 | S-3 | |
| 2026-03-11 | 8-K | 8-K items 8.01,9.01 | 2026-03-11 |
| 2026-03-11 | 424B5 | 424B5 | |
| 2026-03-06 | 4 | 4 | 2026-03-05 |
| 2026-03-06 | 4 | 4 | 2026-03-05 |
| 2026-03-06 | 4 | 4 | 2026-03-05 |
Forms on file (last 1,000): 8-K 341, 4 305, 10-Q 43, SC 13D/A 40, 3 29, 424B5 21, DEFA14A 20, 5 19. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=LCTX (0.002 USD), /gw/filings/filings?ticker=LCTX&form=8-K, /gw/filings/facts?ticker=LCTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange